San Francisco’s pilot program for drug disposal is being hailed as a success, but it will end in June unless more funding can be found.
The City has suffered setbacks during its long struggle to ensure the safe disposal of unwanted medicines. Most recently, lawmakers were on the verge of passing legislation requiring pharmaceutical companies to fund and operate a drug take-back program.
(Editor's note: The following article was written prior to the State of the Union address.) Read More
Not a lot of details have emerged yet about the FDA's decison to revoke approval for Avastin, aside from this brief notice at the Washington Post. Read More